Relapsed/Refractory B-cell Lymphomas
3 clinical trials · Condition
◉ Watch Relapsed/Refractory B-cell Lymphomas
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T (NCT04488354) | Calibr, a division of Scripps Research | 2021-01-21 |
| CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies (NCT04450069) | Calibr, a division of Scripps Research | 2020-08-14 |
Track Relapsed/Refractory B-cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.